Koyfin Home > Directory > Health Care > Amicus Therapeutics > Total Debt / (EBITDA-CAPEX)

Amicus Therapeutics Total Debt / (EBITDA-CAPEX) Chart (FOLD)

Amicus Therapeutics annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Amicus Therapeutics Total Debt / (EBITDA-CAPEX) for the quarter ending March 03, 2020 was $-1m a 11.33% decrease of 0m year over year
  • Amicus Therapeutics Total Debt / (EBITDA-CAPEX) for the last 12 months ending March 03, 2020 was $-1m a 29.86% decrease of 0m year over year
  • Amicus Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2019 was $-1m a -40.09% increase of 0m from 2018
  • Amicus Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2018 was $-1m a 17.79% decrease of 0m from 2017
  • Amicus Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2017 was $-1m a -7.81% increase of 0m from 2016
Other Ratios Metrics:
  • Amicus Therapeutics Total Debt / Capital for the quarter ending September 09, 2018 was $44m a 27.22% increase of 12m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Debt / Equity for the quarter ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
View Chart On Koyfin

Quarterly FOLD Total Debt / (EBITDA-CAPEX) Data

03/2020$-1m
12/2019$-1m
09/2019$-1m
06/2019$-1m
03/2019$-1m
12/2018$-1m
09/2018$-1m
06/2018$-1m
03/2018$-1m
12/2017$-1m

Annual FOLD Total Debt / (EBITDA-CAPEX) Data

2019$-1m
2018$-1m
2017$-1m
2016$-1m
2015$0m
2014$0m
2013$0m
2012$0m
2011$0m
2010$0m